64Cu-NBC-02

N/A

Report date: 2025/06/11 10:21:20

Base Information

Drug Name64Cu-NBC-02

Drug Alias Name64Cu-labeled anti-PSMA nanobody (GeneQuantum Healthcare)64Cu-labelled albumin-binder-conjugated PSMA (GeneQuantum Healthcare)anti-PSMA radionuclide-drug conjugate (GeneQuantum Healthcare)64Cu-PSMA-NBC-02Copper-64-labeled anti-PSMA nanobody (GeneQuantum Healthcare)

ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentDiagnostic agent (In vivo)

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsPositron-emission tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A